Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies

Innate immune recognition

Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

Bernard, G. R., Vincent, J., Laterre, P., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,124

Toll-like receptors: critical proteins linking innate and acquired immunity

Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777

Toll-like receptors in the induction of the innate immune response

Aderem, A. A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,082

The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex

Park, B. S., Song, D. H., Kim, H. M., Choi, B., Lee, H., & Lee, J. (2009) · Nature · doi:10.1038/nature07830 · Cited by 2,513

Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin

Ziegler, E. J., Fisher, C. J., Sprung, C. L., Straube, R., SADOFF, J. C., Foulke, G. E., Wortel, C. H., Fink, M. P., Dellinger, R. P., Teng, N. N. H., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102143240701 · Cited by 1,618

Bacterial endotoxin: molecular relationships of structure to activity and function

Rietschel, E., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zähringer, U., Seydel, U., Padova, F. D., et al. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.2.8119492 · Cited by 1,608

High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes

Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401

Bacterial lipopolysaccharides and innate immunity

Alexander, C., & Rietschel, E. T. (2001) · Journal of Endotoxin Research · doi:10.1179/096805101101532675 · Cited by 1,206

TAP2, a peptide antagonist of Toll-like receptor 4, attenuates pain and cartilage degradation in a monoiodoacetate-induced arthritis rat model

Park, H., Hong, J., Yin, Y., Joo, Y.-B., Kim, Y., Shin, J., Kwon, H. H., Shin, N., Shin, H. J., Beom, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74544-5 · Cited by 19

Alternatively Spliced Myeloid Differentiation Protein-2 Inhibits TLR4-Mediated Lung Inflammation

Tumurkhuu, G., Dagvadorj, J., Jones, H. D., Chen, S., Shimada, K., Crother, T. R., & Arditi, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402123 · Cited by 18

Structural insights into pharmacophore-assistedin silicoidentification of protein–protein interaction inhibitors for inhibition of human toll-like receptor 4 – myeloid differentiation factor-2 (hTLR4−MD-2) complex

Mishra, V., & Pathak, C. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1474804 · Cited by 18

Disaccharide‐Based Anionic Amphiphiles as Potent Inhibitors of Lipopolysaccharide‐Induced Inflammation

Borio, A., Holgado, A., Gárate, J. A., Beyaert, R., Heine, H., & Zamyatina, A. (2018) · ChemMedChem · doi:10.1002/cmdc.201800505 · Cited by 19

sTLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS

Zou, Y., Qin, F., Chen, J., Meng, J., Liuhua, W., Wu, C., Zhang, Q., Dong, W., Chen, X., Wu, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10496 · Cited by 18

Novel peptide and hyaluronic acid coated biomimetic liposomes for targeting bacterial infections and sepsis

Ismail, E. A., Omolo, C. A., Gafar, M. A., Khan, R. B., Nyandoro, V. O., Yakubu, E. S., Mackraj, I., Tageldin, A., & Govender, T. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124493 · Cited by 17

Endogenous Ligands of TLR4 in Microglia: Potential Targets for Related Neurological Diseases

Chen, B., & Di, B. (2024) · Current Drug Targets · doi:10.2174/0113894501316051240821060249 · Cited by 16

Targeting Toll like Receptors in Cancer: Role of TLR Natural and Synthetic Modulators

Narayanankutty, A., Sasidharan, A., & Job, J. T. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200720235058 · Cited by 17

Toll-like receptor-4 antagonism mediates benefits during neuroinflammation

Agrawal-Rajput, R., Gaikwad, S., & Challagundla, N. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.180732 · Cited by 16

Modulating the biosynthesis and TLR4-interaction of lipopolysaccharide as an approach to counter gut dysbiosis and Parkinson's disease: Role of phyto-compounds

Roy, R., Kumar, D., Bhattacharya, P., & Borah, A. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105803 · Cited by 17

Anti-inflammatory effects of benzenediamine derivate FC-98 on sepsis injury in mice via suppression of JNK, NF-κB and IRF3 signaling pathways

Song, Y., Liu, X., Yue, H., Ji, J., Dou, H., & Hou, Y. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.05.005 · Cited by 15

HCC Is promoted by bacterial translocation and TLR-4 signaling: A new paradigm for chemoprevention and management

Toffanin, S., Cornellà, H., Harrington, A., Llovet, J. M., Groszmann, R. J., Iwakiri, Y., & Taddei, T. H. (2012) · Hepatology · doi:10.1002/hep.26080 · Cited by 15

Behavioral effects of toll-like receptor-4 antagonist ‘eritoran’ in an experimental model of depression: role of prefrontal and hippocampal neurogenesis and γ-aminobutyric acid/glutamate balance

Aboul‐Fotouh, S., Habib, M. Z., Asaad, T., Kassim, S. K., & Ghanem, M. H. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000390 · Cited by 15

Potential Roles of Myeloid Differentiation Factor 2 on Neuroinflammation and Its Possible Interventions

Oo, T. T., Pratchayasakul, W., Chattipakorn, N., & Chattipakorn, S. C. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02066-2 · Cited by 15

Glycolipid‐based TLR 4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties

Ciaramelli, C., Calabrese, V., Sestito, S. E., Pérez-Regidor, L., Klett, J., Oblak, A., Jerala, R., Piazza, M., Martín‐Santamaría, S., & Peri, F. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12749 · Cited by 15

Toll-like receptor 4 in the interface between neuroimmune response and behavioral alterations caused by stress

de Souza-Júnior, F. J. C., Cunha, L. C., & Lisboa, S. F. D. S. (2022) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2022.00028 · Cited by 16

Ablation of Myeloid Cell MRP8 Ameliorates Nephrotoxic Serum-induced Glomerulonephritis by Affecting Macrophage Characterization through Intraglomerular Crosstalk

Hata, Y., Kuwabara, T., Mori, K., Kan, Y., Sato, Y., Umemoto, S., Fujimoto, D., Kanki, T., Nishiguchi, Y., Yokoi, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-59970-9 · Cited by 13

Antimicrobial peptide-fucoidan nanoplexes: A novel multifunctional biomimetic nanocarrier for enhanced vancomycin delivery against bacterial infections and sepsis

Gafar, M. A., Omolo, C. A., Ibrahim, U. H., Peters, X. Q., Ismail, E. A., Khan, R. B., & Govender, T. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125344 · Cited by 13

Emerging Strategies and Progress in the Medical Management of Marburg Virus Disease

Musafiri, S., Siddig, E. E., Nkuranga, J. B., Rukundo, A., Mpunga, T., Sendegeya, A., Twagirumugabe, T., Ahmed, A., & Muvunyi, C. M. (2025) · Pathogens · doi:10.3390/pathogens14040322 · Cited by 13

Inhibition of toll-like receptor 4 activation by apigenin and chrysin via competition for sites and conformational changes

Xiao, S., Zhang, P., Zhang, G., Li, W., Lin, H., & Hu, X. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126415 · Cited by 12

Syk: a new target for attenuation of Helicobacter pylori-induced gastric mucosal inflammatory responses

Slomiany, B. L., & Slomiany, A. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00577-6 · Cited by 12

Structural Diversity and Mutational Challenges of Toll‐Like Receptor 4 Antagonists as Inflammatory Pathway Blocker

Rahaman, S. K. B., Nandi, S. K., Mandal, S. K., & Debnath, U. (2024) · Drug Development Research · doi:10.1002/ddr.70031 · Cited by 12

Prevention of Acute Lung Injury by a Novel CD14-Inhibitory Receptor Activator of the NF-κB Ligand Peptide in Mice

Ju, N., Hayashi, H., Shimamura, M., Yoshida, S., Nakamaru, R., Hironori Nakagami, A., Morishita, R., & Rakugi, H. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2000112 · Cited by 11

Synthesis of Bacterial Glycoconjugates and Their Bio-functional Studies in Innate Immunity

Fukase, K., Fujimoto, Y., Shimoyama, A., & Tanaka, K. (2012) · Journal of Synthetic Organic Chemistry Japan · doi:10.5059/yukigoseikyokaishi.70.113 · Cited by 11

Specific TLR4 Blocking Effect of a Novel 3,4-Dihydropyrimidinone Derivative

Zhou, M., Wang, Y., Lin, X., Wan, J., & Wen, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.624059 · Cited by 10

A novel small molecule, HK-156, inhibits lipopolysaccharide-induced activation of NF-κB signaling and improves survival in mouse models of sepsis

Fang, J., Liu, Y., Li, J., Liao, W., Hu, Y., & Ding, K. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.56 · Cited by 10

Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages

Ogawa, N., Nakajima, S., Tamada, K., Yokoue, N., Tachibana, H., Okazawa, M., Oyama, T., Abe, H., Yamazaki, H., Yoshimori, A., et al. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109029 · Cited by 10

Chemical Hybridization of Vizantin and Lipid A to Generate a Novel LPS Antagonist

Yamamoto, H., Oda, M., Kanno, M., Tamashiro, S., Tamura, I., Yoneda, T., Yamasaki, N., Domon, H., Nakano, M., Takahashi, H., et al. (2015) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c15-00828 · Cited by 9

Postprandial low-grade inflammation does not specifically require TLR4 activation in the rat

Hermier, D., Mathé, V., Lan, A., Santini, C., Quignard‐Boulangé, A., Huneau, J., & Mariotti, F. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0220-4 · Cited by 9

Experimental TLR4 inhibition improves intestinal microcirculation in endotoxemic rats

Zhou, J., Soltow, M., Zimmermann, K., Pavlović, D., Johnston, B., & Lehmann, C. (2015) · Microvascular Research · doi:10.1016/j.mvr.2015.06.004 · Cited by 8

miR-6089 Alleviates Inflammation and Cell Apoptosis Through Modulating the TLR4 Pathway in Mite-Sensitized Allergic Rhinitis

Qiu, C.-Y., Bi, J., Cui, X., Chen, R.-X., Luan, Z., Guo, Y., Lu, M., Li, L., & Cheng, L. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s497005 · Cited by 7

The Multifaceted Role of Regulatory T Cells in Sepsis: Mechanisms, Heterogeneity, and Pathogen-Tailored Therapies

Qin, Y., & Zhang, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157436 · Cited by 7

Decrease in the inflammatory cytokines of LPS-stimulated PBMCs of patients with atherosclerosis by a TLR-4 antagonist in the co-culture with HUVECs

Talepoor, A. G., Rastegari, B., Kalani, M., & Doroudchi, M. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108295 · Cited by 9

Enhancing acute inflammatory and sepsis treatment: superiority of membrane receptor blockade

Mun, S., Cho, E., Kim, H. K., Gil, W. J., & Yang, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1424768 · Cited by 6

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Yang, H. Y., Fung, S., Bao, A., Li, Q., & Turvey, S. E. (2017) · Journal of Visualized Experiments · doi:10.3791/56075 · Cited by 6

E5564 inhibits immunosuppressive cytokine IL-10 induction promoted by HIV-1 Tat protein

Bahraoui, E., Briant, L., & Chazal, N. (2014) · Virology Journal · doi:10.1186/s12985-014-0214-z · Cited by 6

Hyaluronic acid-silybin conjugate for the preparation of multifunctional, biomimetic, vancomycin-loaded self-assembled polymersomes against bacterial sepsis

Gafar, M. A., Omolo, C. A., Ibrahim, U. H., Elamin, G., Tageldin, A., Elhassan, E., Ismail, E. A., Mackraj, I., & Govender, T. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140152 · Cited by 5

Targeting lipopolysaccharides in gram-negative sepsis: therapeutic advances and challenges

AKELE, O., Rana, F., Acharya, S., LeDoux, D., & Chalhoub, M. N. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2546487 · Cited by 5

Pattern recognition receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

Bryant, C. E., & Monie, T. P. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f302/2019.4 · Cited by 5

Lipopolysaccharide (LPS) and Protein-LPS complexes: Detection and Characterization by Gel Electrophoresis, Mass Spectrometry and Bioassays

Hardy, E., & Rodríguez, C. (2016) · Biology and Medicine · doi:10.4172/0974-8369.1000277 · Cited by 5

Pattern recognition receptors and the innate immune network

van Hensbergen, V. P., & Hu, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00131-3 · Cited by 4

Bioactive Nanomaterials: Comprehensive Monitoring and Regulation of Acute Pancreatitis Induced Acute Lung Injury

Obeng, E., Ergashev, A., Yao, Q., Wu, W., & Chen, G. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s514653 · Cited by 4

Utilidad de la hemoperfusión en el tratamiento del paciente séptico grave. Actualización

Pestaña, D., Ojeda, N., Padron, O. M., Higuera, E. Q., Rey, T., & Aldecoa, C. (2012) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2012.08.002 · Cited by 3

Bridging the Translational Gap: The Challenges of Novel Drug Development in Critical Care

Lambden, S., & Summers, C. (2017) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-319-51908-1_30 · Cited by 3

Small Molecule Modulators of Endo-lysosomal Toll-like Receptors

Talukdar, A., Mukherjee, A., & Ganguly, D. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00339 · Cited by 3

Diabetes mellitus influences Toll-like receptors 2 and 4 in experimental apical periodontitis of Wistar rats

Machado, N. E. D. S., Segura-Egea, J. J., Faria, F. D., da Silva, C. C., Ribeiro, A. P. F., Ervolino, E., Matsushita, D. H., Estrela, C., Cruz, Á., Gomes‐Filho, J. E., et al. (2025) · Odontology · doi:10.1007/s10266-025-01147-9 · Cited by 2

Synthesis of bioactive lipid A and analogs

Zamyatina, A., & Strobl, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820954-7.00003-7 · Cited by 2

Microbiota, Inflammation, and Gut Barrier Dysfunction in HCC

Ram, A. K., Wright, G. A. K., & Vairappan, B. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89578 · Cited by 2

Glycans in Medicinal Chemistry

Lacetera, A., Galante, S., Jiménez‐Barbero, J., & Martín‐Santamaría, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.11712-3 · Cited by 2

Exploring the Binding Proteins of Glycolipids with Bifunctional Chemical Probes

Liu, X., Dong, T., Zhou, Y., Huang, N., & Lei, X. (2016) · Angewandte Chemie · doi:10.1002/ange.201608827 · Cited by 2

Identification and mechanistic insights into immunomodulatory peptides from soft-shelled turtle hydrolysates

Wu, Y., Wang, G., Shi, L., Zhu, X., & Yan, F. (2026) · Food Chemistry · doi:10.1016/j.foodchem.2026.148512 · Cited by 1

Targeting MD2 in diseases: from structure and function to inhibitor development

Cheng, F., Yang, F., Xiao, S., Zhou, Y., Wu, Y., Zhang, J., & He, Z. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119157 · Cited by 1

Gut Microbiota and HCC

Loosen, S. H., Roderburg, C., & Luedde, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-34214-6_9 · Cited by 1

Vitexin as a Potential Inhibitor for the Activation of Microglial Cells: Insights from Molecular Docking and Molecular DynamicsPreprint

Yahaya, M. A. F., Bakar, A. R. A., Stanslas, J., Nordin, N., Zainol, M., & Mehat, M. Z. (2021) · Research Square · doi:10.21203/rs.3.rs-136804/v1 · Cited by 1

Programmed inhibition of an innate immune receptor via de novo designed transmembrane proteinsPreprint

Maillie, C. A., Zhang, M., Gosiet, N., Goldenfeld, G., Ward, A. B., & Mravic, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.31.657109 · Cited by 1

Therapeutic role of Filarial HSP70 in murine models of polymicrobial sepsis and H1N1 InfluenzaPreprint

Patel, P., Siddappa, S., Ravindran, B., & Saiyed, T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.17.460786

Pattern recognition receptors in GtoPdb v.2021.3

Bryant, C. E., & Monie, T. P. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f302/2021.3

Faculty Opinions recommendation of Computational Approaches to Toll-Like Receptor 4 Modulation.

Weiss, J. P. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726631659.793545001

Faculty Opinions recommendation of TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis.

Pierro, A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732009889.793555356

Pattern recognition receptors in GtoPdb v.2023.1

Bryant, C. E., & Monie, T. P. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f302/2023.1

Andrographolide inhibits the activation of spinal microglia and ameliorates mechanical allodynia

Wang, D., Zheng, Y., Xie, J., Yu, W., Lu, Z., Zhang, W., Hu, Y., Fu, J., Sheng, Q., & Lv, Z. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01325-0

Avaliação das consequências comportamentais da administração de um inibidor da via do TLR4 no córtex pré-frontal medial após exposição ao estresse e possível envolvimento do sistema endocanabinoide

de Souza, F. J. C. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2023.tde-10112023-160939

Small-Molecule Modulators of Toll-Like Receptor Signaling and Their Clinical Applications

Matsunaga, N. (2024) · Premier journal of science. · doi:10.70389/pjs.100031

Screening and validation of key genes for pediatric sepsis based on bioinformatics analysisPreprint

Zheng, S., Luo, Z., Zhang, M., & Zhao, W. (2025) · Research Square · doi:10.21203/rs.3.rs-7372938/v1

Endotoxic septic shock

Kamaluddin, E., & Foster, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33074-2.00011-1

Sepsis and endotoxin: A brief history

Foster, D., & Kellum, J. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33074-2.00003-2

Recent advances in the design and development of small molecules targeting the TLR4 signaling pathway

Ishfaq, M., Shahab, M., & Jiang, G. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2648983

Long non-coding RNAs as regulators of immune signaling pathways in esophageal cancer

Uttam, V., Rana, M. K., Sethi, G., & Jain, A. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117987

Akkermansia muciniphila-derived postbiotics reprogram immune balance to combat sepsis via the IDO1/Kyn/AhR metabolic axis

Zhang, Y., Yin, R., Dong, W., Sun, L., Wang, T., Sun, J., Dai, H., Bi, Y., Wang, L., & Liu, H. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.07.010

BindingDB Entry 50001550: Discovery of caffeic acid phenethyl ester derivatives as novel myeloid differentiation protein 2 inhibitors for treatment of acute lung injury.

BindingDB (2020) · UC San Diego · doi:10.7270/q2sb488m

BindingDB Entry 50016447: Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective.

BindingDB (2023) · UC San Diego · doi:10.7270/q2vq36qn

BindingDB Entry 50043595: Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening.

BindingDB (2014) · UC San Diego · doi:10.7270/q2hq41cc

BindingDB Entry 50004195: Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury.

BindingDB (2021) · UC San Diego · doi:10.7270/q2668hfm

Safety, pharmacokinetics, and pharmacodynamics of 4-hour intravenous infusion of eritoran tetrasodium in healthy Japanese and Caucasian males

Okubo, Y., Aikawa, N., Lynn, M., Rossignol, D. P., Wong, Y., Schuck, E. L., Kitahara, Y., Nakano, T., Sivak, O., Wasan, K. M., et al. (2011) · Critical Care · doi:10.1186/cc9685 · Cited by 2

Clinical Application of Eritoran as Drug Candidate for Sepsis Treatment

Park, S. H., Lee, K., Lim, H. K., Han, S., & Kim, Y. S. (2011)

Risk of death and the efficacy of eritoran tetrasodium (E5564): Design considerations for clinical trials of anti-inflammatory agents in sepsis*

Barochia, A. V., Cui, X., Natanson, C., & Eichacker, P. Q. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b77fe3 · Cited by 12

Eritoran: the evidence of its therapeutic potential in sepsis

Raja, R. (2007) · Core evidence · doi:10.2147/ce.s7430 · Cited by 7

Influence of Severity of Illness on the Effects of Eritoran Tetrasodium (E5564), a TLR4 Antagonist, in Patients with Severe Sepsis.

Kalil, A. C., LaRosa, S. P., Gogate, J. P., Lynn, M., Wittek, A. E., & Opal, S. M. (2009) · doi:10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a4696